VIOXX- recall
NEWS ALERT: VIOXX users & family,
You may be entitled to compensation
Our solicitor referral service is independent and completely FREE.
Just complete the Contact Form and a solicitor will contact you and provide you with obligation-free advice.
Vioxx is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). Vioxx is also related to the nonselective NSAIDs , such as ibuprofen and naproxen. Vioxx is a prescription medicine produced by Merck & Company that is used to relieve signs, pain from, and symptoms of arthritis, acute pain in adults, and painful menstrual cycles. The US Food And Drug Administration originally approved Vioxx in May of 1999.
For several years, lawyers have been asserting that Merck was aware of problems experienced by patients taking Vioxx, including problems with stomach ulcers and liver damage, but also including heart problems and kidney damage. They allege that Merck deliberately suppressed information about these side effects from patients and physicians.
Two prominent medical journals have published articles which associate Vioxx use with a significantly heightened risk of heart attack. These side effects are believed to be most likely to occur in patients who took Vioxx for fifteen months or longer.
Merck’s decision to withdraw and recall Vioxx from the market is based on new data from a trial called the APPROVe [ Adenomatous Polyp Prevention on VIOXX] trial. In the APPROVe trial, Vioxx was compared to a sugar-pill and the results indicated that exposure to Vioxx caused an increased risk in cardiovascular events such as heart attack and strokes.
Merck is the world's third largest drug maker. VIOXX accounted for $2.5 billion in sales in 2003. More than 2 million people take VIOXX worldwide.
If you or your loved ones have had an adverse reaction since beginning to take Vioxx and would like more information on the Vioxx recall and your legal rights to compensation, please use the form on the right of this page to contact one of our experienced personal injury lawyers today.
The US Food and Drug Administration (FDA) acknowledged the voluntary withdrawal from the market of Vioxx (chemical name rofecoxib), a non-steroidal anti-inflammatory drug (NSAID) manufactured by Merck & Co. FDA also issued a Public Health Advisory to inform patients of this action and to advise them to consult with a physician about alternative medications-
FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Withdraws the Product
VIOXX RECALL NOTICE ON AUSTRALIAN TGA SITE:
Vioxx (Rofecoxib)
Medicine recall
Level: Consumer
Class: II
Reference: R2004/1226-9
Date: 1 October 2004
From: TGA Recalls
Product:
VIOXX (Rofecoxib) tablets 12.5mg (AUST R 69872)
VIOXX (Rofecoxib) tablets 25mg (AUST R 69871)
VIOXX (Rofecoxib) oral suspension 12.5mg/5mL (AUST R 69870)
VIOXX (Rofecoxib) oral suspension 25mg/5mL (AUST R 69869)
Batch No.: ALL BATCHES
Sponsor: Merck Sharp & Dohme Pty Ltd
Phone: 1800 066 426 Customer Service Line
Reason: The company has decided to recall VIOXX based on new information from a recent clinical study which showed that there was an increased risk of cardiovascular events such as heart attack and stroke beginning after 18 months of treatment, in the patients taking Vioxx at a dose of 25 mg once daily.
Recall letters will be dispatched from today 1 October 2004. Recall notices are expected to appear in newspapers on Saturday 2 October 2004.
Media release - Consumer level recall of arthritis drug
Our lawyers specialise in pharmaceutical compensation litigation. They will ensure that your rights and privileges under the law are upheld.
If you would like further information about the vioxx recall and making a Vioxx compensation claim please complete the contact form and a Lawyer will be in touch with you.
This referral service is completely obligation-free.
Links:
The Vioxx Recall (Four Corners program, ABC)
|
